{"id":7160,"date":"2017-11-01T16:50:05","date_gmt":"2017-11-01T23:50:05","guid":{"rendered":"https:\/\/www.bluerocktx.com\/?p=7160"},"modified":"2023-06-26T14:37:59","modified_gmt":"2023-06-26T18:37:59","slug":"bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/","title":{"rendered":"BlueRock Therapeutics Announces Appointment of its CEO and President to The Alliance for Regenerative Medicine 2018 Executive Committee and Board of Directors"},"content":{"rendered":"<p><strong>NEW YORK and CAMBRIDGE, Mass., Nov. 1, 2017<\/strong>\u00a0\u2014 BlueRock Therapeutics, a company developing cell-based therapies designed to alter the course of degenerative disease, today announced that its president and chief executive officer, Emile Nuwaysir, Ph.D., has been appointed to The Alliance for Regenerative Medicine (ARM) 2018 Executive Committee and Board of Directors.<\/p>\n<p>\u201cWith a mission to facilitate access to life-giving advances in regenerative medicine worldwide, ARM represents a leading organization in our field and one in which I\u2019m proud to play a role,\u201d said Dr. Nuwaysir. \u201cI am joining a board of accomplished leaders and scientists who share a vision to advance the entire regenerative medicine community by working to increase public understanding of the field and promote legislative, regulatory and reimbursement initiatives to create a clear path to deliver disease altering treatments for patients.\u201d<\/p>\n<p>The Executive Committee and Board of Directors oversee the formation and execution of ARM\u2019s strategic priorities and focus areas over the coming year. Each group is held to an annual reelection or rotation process, with nominations and approval by the ARM membership and current Board.<\/p>\n<p><strong>About BlueRock Therapeutics<\/strong><\/p>\n<p>Driven by a vision to liberate patients from the burden of degenerative disease, BlueRock Therapeutics is ushering in a new era of cell-based medicine that repairs the body when it cannot repair itself. Founded in 2016 through one of the largest Series A financings in biotech history, BlueRock and its team of preeminent scientists are pioneering cell therapies that replace dead, damaged or dysfunctional cells to restore critical natural functions in the body. Using an approach that can be applied to multiple diseases with great unmet need, BlueRock is initially targeting severe brain and heart conditions, with the goal of altering the course of disease and drastically improving quality of life. BlueRock\u2019s culture is defined by scientific innovation, highest ethical standards and an urgency to bring transformative treatments to all who would benefit. For more information, visit <a href=\"http:\/\/www.bluerocktx.com\">www.bluerocktx.com<\/a>.<\/p>\n<p>Media Contact<br \/>\nJessica Dyas<br \/>\nCanale Communications<br \/>\n<a href=\"mailto:jessica@canalecomm.com\">jessica@canalecomm.com<\/a><br \/>\n619-849-5385<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK and CAMBRIDGE, Mass., Nov. 1, 2017\u00a0\u2014 BlueRock Therapeutics, a company developing cell-based therapies designed to alter the course of degenerative disease, today announced that its president and chief executive officer, Emile Nuwaysir, Ph.D., has been appointed to The Alliance for Regenerative Medicine [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":7708,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[45],"tags":[54],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BlueRock Therapeutics Announces Appointment of its CEO and President to The Alliance for Regenerative Medicine 2018 Executive Committee and Board of Directors - BlueRock Therapeutics LP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BlueRock Therapeutics Announces Appointment of its CEO and President to The Alliance for Regenerative Medicine 2018 Executive Committee and Board of Directors - BlueRock Therapeutics LP\" \/>\n<meta property=\"og:description\" content=\"NEW YORK and CAMBRIDGE, Mass., Nov. 1, 2017\u00a0\u2014 BlueRock Therapeutics, a company developing cell-based therapies designed to alter the course of degenerative disease, today announced that its president and chief executive officer, Emile Nuwaysir, Ph.D., has been appointed to The Alliance for Regenerative Medicine [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"BlueRock Therapeutics LP\" \/>\n<meta property=\"article:published_time\" content=\"2017-11-01T23:50:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-26T18:37:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/BR-Logo-Card.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"BlueRock Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BlueRock Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/\",\"url\":\"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/\",\"name\":\"BlueRock Therapeutics Announces Appointment of its CEO and President to The Alliance for Regenerative Medicine 2018 Executive Committee and Board of Directors - BlueRock Therapeutics LP\",\"isPartOf\":{\"@id\":\"https:\/\/www.bluerocktx.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/BR-Logo-Card.jpg\",\"datePublished\":\"2017-11-01T23:50:05+00:00\",\"dateModified\":\"2023-06-26T18:37:59+00:00\",\"author\":{\"@id\":\"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/#primaryimage\",\"url\":\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/BR-Logo-Card.jpg\",\"contentUrl\":\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/BR-Logo-Card.jpg\",\"width\":900,\"height\":1000,\"caption\":\"BlueRock Therapeutics Logo Card\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.bluerocktx.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BlueRock Therapeutics Announces Appointment of its CEO and President to The Alliance for Regenerative Medicine 2018 Executive Committee and Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.bluerocktx.com\/#website\",\"url\":\"https:\/\/www.bluerocktx.com\/\",\"name\":\"BlueRock Therapeutics LP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.bluerocktx.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057\",\"name\":\"BlueRock Therapeutics\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.bluerocktx.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g\",\"caption\":\"BlueRock Therapeutics\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BlueRock Therapeutics Announces Appointment of its CEO and President to The Alliance for Regenerative Medicine 2018 Executive Committee and Board of Directors - BlueRock Therapeutics LP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"BlueRock Therapeutics Announces Appointment of its CEO and President to The Alliance for Regenerative Medicine 2018 Executive Committee and Board of Directors - BlueRock Therapeutics LP","og_description":"NEW YORK and CAMBRIDGE, Mass., Nov. 1, 2017\u00a0\u2014 BlueRock Therapeutics, a company developing cell-based therapies designed to alter the course of degenerative disease, today announced that its president and chief executive officer, Emile Nuwaysir, Ph.D., has been appointed to The Alliance for Regenerative Medicine [&hellip;]","og_url":"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/","og_site_name":"BlueRock Therapeutics LP","article_published_time":"2017-11-01T23:50:05+00:00","article_modified_time":"2023-06-26T18:37:59+00:00","og_image":[{"width":900,"height":1000,"url":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/BR-Logo-Card.jpg","type":"image\/jpeg"}],"author":"BlueRock Therapeutics","twitter_card":"summary_large_image","twitter_misc":{"Written by":"BlueRock Therapeutics","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/","url":"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/","name":"BlueRock Therapeutics Announces Appointment of its CEO and President to The Alliance for Regenerative Medicine 2018 Executive Committee and Board of Directors - BlueRock Therapeutics LP","isPartOf":{"@id":"https:\/\/www.bluerocktx.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/BR-Logo-Card.jpg","datePublished":"2017-11-01T23:50:05+00:00","dateModified":"2023-06-26T18:37:59+00:00","author":{"@id":"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057"},"breadcrumb":{"@id":"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/#primaryimage","url":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/BR-Logo-Card.jpg","contentUrl":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/06\/BR-Logo-Card.jpg","width":900,"height":1000,"caption":"BlueRock Therapeutics Logo Card"},{"@type":"BreadcrumbList","@id":"https:\/\/www.bluerocktx.com\/bluerock-therapeutics-announces-appointment-of-its-ceo-and-president-to-the-alliance-for-regenerative-medicine-2018-executive-committee-and-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.bluerocktx.com\/"},{"@type":"ListItem","position":2,"name":"BlueRock Therapeutics Announces Appointment of its CEO and President to The Alliance for Regenerative Medicine 2018 Executive Committee and Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.bluerocktx.com\/#website","url":"https:\/\/www.bluerocktx.com\/","name":"BlueRock Therapeutics LP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bluerocktx.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057","name":"BlueRock Therapeutics","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bluerocktx.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g","caption":"BlueRock Therapeutics"}}]}},"_links":{"self":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts\/7160"}],"collection":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/comments?post=7160"}],"version-history":[{"count":7,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts\/7160\/revisions"}],"predecessor-version":[{"id":7657,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts\/7160\/revisions\/7657"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/media\/7708"}],"wp:attachment":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/media?parent=7160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/categories?post=7160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/tags?post=7160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}